重症监护室中右美托咪定的经验性使用:结构化共识报告
该结构化共识由17名在疼痛、躁动和谵妄(PAD)管理及右美托咪定(DEX)使用方面经验丰富的重症医生制定,采用改良RAND/UCLA适宜性方法。在四类预设患者人群中识别出现有推荐药物策略(除DEX外)应对不佳的临床场景,经文献回顾后投票。共识别出医疗患者3个场景、急性呼吸衰竭接受无创通气患者5个场景、心脏术后早期患者3个场景及明显谵妄患者3个场景。多数专家投票认为DEX因保留认知功能、不影响呼吸驱动、低谵妄诱导及镇痛作用而可能有用。结论认为DEX可能在不同场景中作为一线镇静考虑,尽管其获益的确切数据仍缺乏。
要点
- 共识针对四类人群:医疗患者、急性呼吸衰竭接受无创通气者、心脏术后早期患者、明显谵妄患者。
- 在现有PAD策略应对不佳的特定场景中,多数专家投票认为使用DEX可能有用。
- DEX的特定药理特性包括保留认知功能、不影响呼吸驱动、低谵妄诱导及镇痛作用。
- 结论认为DEX可能在不同场景中作为一线镇静考虑,但获益的确切数据仍缺乏。
适用人群与场景
- 医疗患者
- 急性呼吸衰竭接受无创通气的患者
- 心脏术后早期患者
- 明显谵妄患者
研究设计与关键结果
- 采用改良RAND/UCLA适宜性方法,由17名在PAD管理和DEX使用方面经验丰富的重症医生参与。
- 识别出医疗患者3个场景、急性呼吸衰竭接受无创通气患者5个场景、心脏术后早期患者3个场景、明显谵妄患者3个场景,这些场景现有推荐药物策略(除DEX外)应对不佳。
- 在上述场景中,多数专家投票认为DEX因保留认知功能、不影响呼吸驱动、低谵妄诱导及镇痛作用而可能有用。
证据类型、等级与局限
- 证据类型:结构化共识(改良RAND/UCLA适宜性方法)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在现有PAD策略应对不佳的特定场景中,DEX可能作为一线镇静考虑,但获益的确切数据仍缺乏。
指南或共识出处
- Turk J Anaesthesiol Reanim
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: Management of pain, agitation and delirium (PAD) remains to be a true challenge in critically ill patients. The pharmacological proprieties of dexmedetomidine (DEX) make it an ideal candidate drug for light and cooperative sedation, but many practical questions remain unanswered. This structured consensus from 17 intensivists well experienced on PAD management and DEX use provides indications for the appropriate use of DEX in clinical practice.
METHODS: A modified RAND/UCLA appropriateness method was used. In four predefined patient populations, the clinical scenarios do not properly cope by the current recommended pharmacological strategies (except DEX), and the possible advantages of DEX use were identified and voted for agreement, after reviewing literature data.
RESULTS: Three scenarios in medical patients, five scenarios in patients with acute respiratory failure undergoing non-invasive ventilation, three scenarios in patients with cardiac surgery in the early postoperative period and three scenarios in patients with overt delirium were identified as challenging with the current PAD strategies. In these scenarios, the use of DEX was voted as potentially useful by most of the panellists owing to its specific pharmacological characteristics, such as conservation of cognitive function, lack of effects on the respiratory drive, low induction of delirium and analgesia effects.
CONCLUSION: DEX might be considered as a first-line sedative in different scenarios even though conclusive data on its benefits are still lacking.
参考来源
- Pasero D, Sangalli F, Baiocchi M, et al. Experienced Use of Dexmedetomidine in the Intensive Care Unit: A Report of a Structured Consensus. Turk J Anaesthesiol Reanim. 2017. PMID: 30140512. doi:10.5152/TJAR.2018.08058
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。